Thought Leadership

Blog-1

Algorithms Do Not A Company Make

Algorithms Do Not A Company Make

By Dan Lambert, Technology Partner at SpringTide The Health IT industry is full of companies touting useful inventions for patient care, workflow optimization and EMR…

Blog-2

Necessity Is the Mother of Invention

Necessity Is the Mother of Invention

By Austin Walters, Managing Partner of SpringTide

Living in a markedly different cultural environment, I began to learn that societies develop comparative strengths and weaknesses over time in response to conditions on the ground.

Blog-1

SpringTide’s “n of 1” Philosophy

SpringTide’s “n of 1” Philosophy

The idea is counterintuitive; everyone knows that in order to produce illuminating, actionable results, researchers should assemble large, diverse pools of research subjects – the largest they can handle – and see what insights they can skim out of this “Big Data.”

pathologywatch-blog

PathologyWatch Radically Improves Skin Cancer Diagnostics for Dermatologists

PathologyWatch Radically Improves Skin Cancer Diagnostics for Dermatologists

SpringTide was a Major Investor in PathologyWatch’s $3M Series Seed round in early 2019, taking a board seat. We continued to support the company through 2019 with Elastic Sales, building the in-house sales force, and led PathologyWatch’s $5M Series A round in early 2020, doubling the valuation within one year.

Whether you are an entrepreneur or an investor, we’d love to hear from you.